Search Results (4,248)

Soybeans are highly susceptible to drought stress, which significantly impairs their growth and yield. Silicon (Si) supplementation has emerged as a promising strategy to mitigate drought-induced damage in plants. We investigated changes in the physiological and chloroplast proteomes in soybeans under drought stress, both with and without Si supplementation. Soybean plants were grown under controlled conditions and subjected to drought stress. The treatments included Si application (sodium silicate), sodium chloride control, and water control. Chloroplast proteins were extracted from control and Si-treated plants and analyzed using two-dimensional gel electrophoresis and mass spectrometry. Plants treated with Si showed improved drought tolerance, exhibiting reduced leaf rolling and wilting, while the control plants experienced significant wilting under drought conditions. Photosynthetic performance, measured by quantum efficiency of photosystem II and chlorophyll content, was better maintained in Si-supplemented plants under drought. However, stomatal conductance and transpiration were similarly reduced across all drought treatments. We detected 15 Si-responsive protein spots corresponding to 13 unique chloroplast proteins that were differentially expressed in response to Si supplementation. These identified proteins include those involved in photosynthesis, such as Rubisco activase isoforms, oxygen-evolving enhancer proteins, and PsbP domain-containing protein, as well as stress response proteins like dehydrin and 20 kDa chaperonin. Si treatment upregulated Rubisco activase isoforms, oxygen-evolving enhancer proteins, PsbP domain-containing protein, and 20 kDa chaperonin, which are typically reduced under drought. Si treatment maintained a higher glutamine synthetase level under drought stress. Gene ontology and KEGG pathway analyses revealed that Si-modulated proteins are associated with photosynthesis, energy metabolism, and nitrogen metabolism under drought stress. Our findings demonstrate that Si supplementation alleviates drought stress in soybean by preserving chloroplast function and enhancing the expression of photosynthetic proteins and enzymes, as well as key stress-responsive proteins. This research provides insights into the molecular mechanisms of Si-induced drought tolerance in soybeans and highlights potential targets for developing drought-resilient soybean cultivars. Full article

Phosphorus is a fundamental macronutrient, yet its low bioavailability in most soils makes phosphorus deficiency one of the most persistent constraints limiting global crop productivity. Although mineral fertilisation has long been the primary strategy for maintaining adequate P supply, inefficient fertiliser use and strong soil phosphorus fixation result in substantial losses. As a result, current research is shifting toward integrated phosphorus management approaches that combine optimised fertilisation techniques, unconventional phosphorus sources, and biological tools that mobilise soil-bound phosphorus. At the same time, silicon has emerged as a promising modulator of plant stress resilience, which can also influence phosphorus homeostasis. Silicon enhances plant physiological robustness by strengthening tissues, improving photosynthetic performance, and activating antioxidant pathways. Silicon may also modify phosphorus mobility in soils, promoting more efficient uptake and utilisation in plant tissues. This review synthesises current knowledge on physiological and molecular plant responses to phosphorus deficiency. It compares modern fertilisation strategies, ranging from precision fertilisation to unconventional phosphorus fertilisers. Particular attention is devoted to the emerging role of silicon in improving phosphorus availability and in enhancing crop plant phosphorus-use efficiency. The review concludes with future research directions that may help integrate silicon-based interventions into sustainable nutrient-management systems. Full article

Pseudorabies (PR) is an acute and highly contagious disease caused by the pseudorabies virus (PRV). This virus has a wide range of susceptible hosts and has caused major economic losses to the global swine industry. While rosmarinic acid possesses broad antioxidant and antiviral properties, its efficacy against PRV has remained unexplored. Therefore, this study aimed to evaluate the anti-PRV activity of rosmarinic acid and to elucidate its underlying mechanism, with a focus on the nuclear factor erythroid 2-related factor 2 (Nrf2) signaling pathway. The results revealed that rosmarinic acid exhibited potent, concentration-dependent antiviral activity in vitro, with a half-maximal inhibitory concentration (IC50) of 0.02654 mg/mL, a half-maximal cytotoxic concentration (CC50) of 0.1043 mg/mL, and a selectivity index (SI) of 3.9. Rosmarinic acid inhibited virus adsorption, entry, and intracellular replication. It also significantly suppressed the expression of the gB protein. In a mouse model, rosmarinic acid treatment (200 mg/kg) significantly enhanced the survival rate to 28.5%. This treatment reduced the viral load in the brain, lungs, kidneys, heart, and spleen. It also alleviated the tissue damage caused by PRV infection. Furthermore, rosmarinic acid counteracted PRV-induced oxidative stress by elevating the activity of the antioxidant factors SOD and CAT and reducing the level of the oxidative factor MDA. Combined network pharmacology and molecular docking analyses predicted the Nrf2 signaling pathway as a key target for rosmarinic acid. Subsequent mechanistic studies confirmed that rosmarinic acid upregulated the expression of the Nrf2, HO-1, GPX, SOD, and CAT genes, as well as Nrf2 and HO-1 proteins, thereby promoting the nuclear translocation of Nrf2. These results identify rosmarinic acid as a promising anti-PRV agent that acts through multi-phase viral inhibition and activation of the Nrf2-mediated antioxidant defense, suggesting its potential as a novel pharmacological strategy against PRV. Full article

Background: Medicinal plants used in traditional Mexican medicine represent a valuable source of bioactive compounds with potential anticancer activity. Beyond cytotoxic potency, selectivity toward cancer cells over normal cells is a critical toxicological parameter for identifying safer therapeutic candidates. This study aimed to evaluate the selective cytotoxic and antiproliferative effects of extracts from four Mexican medicinal plants across human cancerous and non-cancerous cell lines. Methods: Hexane, acetone, and methanolic extracts from Semialarium mexicanum, Eryngium heterophyllum, Piper auritum, and Cochlospermum vitifolium were evaluated in a panel of human cancer cell lines and non-tumoral models, including primary human uterine fibroblasts (HUFs). Cytotoxicity was assessed after 48 h of treatment using increasing extract concentrations, and selectivity indices were calculated. Cell cycle distribution and nuclear morphology analyses were performed to explore antiproliferative effects. Additionally, GC–MS-based chemical profiling was conducted on selected extracts to obtain a tentative characterization of major bioactive constituents. Results: The extracts exhibited differential cytotoxic profiles depending on plant species and solvent polarity. The hexane extract of Semialarium mexicanum showed the highest cytotoxic potency and selectivity toward cervical cancer cells, with half-maximal inhibitory concentration (IC₅₀); values of 15.9 ± 1.8 µg/mL and 17.2 ± 2.8 µg/mL in HeLa and SiHa cells, respectively, and selectivity index (SI) values > 5 when compared with primary human uterine fibroblasts (HUF). Extracts of Eryngium heterophyllum displayed moderate cytotoxic activity (IC₅₀ = 20–30 µg/mL in HeLa cells) with intermediate selectivity, whereas Cochlospermum vitifolium showed solvent-dependent effects and Piper auritum exhibited limited cytotoxicity. Cell cycle analysis revealed an increased sub-G1 population, and nuclear morphology assays demonstrated chromatin condensation and fragmentation in cancer cells, supporting an antiproliferative mechanism. GC–MS analysis of the hexane extract of Semialarium mexicanum suggested the presence of triterpenoid-related and other lipophilic compounds potentially associated with its selective anticancer activity. Conclusions: These findings provide in vitro evidence of selective anticancer activity of Mexican medicinal plant extracts and establish a basis for future mechanistic studies medicinal plant extracts and lay the groundwork for future mechanistic investigations. Full article

Advanced oxidation processes using porphyrin-based heterogeneous catalysts hold promise for removing hazardous pollutants from wastewater. Their high visible-light absorption coefficients enable absorption of light from the solar spectrum. Moreover, their conjugated aromatic skeletons and intrinsic electronic properties facilitate the delocalization of photogenerated electrons during photodegradation. Delaying the recombination of photogenerated electron–hole pairs by introducing specific materials increases efficiency, as separated charges have more time to participate in redox reactions, boosting photocatalytic activities. However, applying these photocatalysts for wastewater treatment is challenging owing to facile agglomeration, deactivation, and recovery of the photocatalyst for reuse, which can significantly increase the overall cost. Therefore, new photocatalytic systems comprising porphyrin molecules must be developed. For this purpose, porphyrins can be conjugated to nanomaterials to create hybrid materials with photocatalytic efficiencies superior to those of free-standing starting porphyrins. Various transition metal oxides (TiO₂, ZnO, and Fe₃O₄) nanoparticles, main-group-element oxides (Al₂O₃ and SiO₂) nanoparticles, metal plasmons (silver nanoparticles), carbon-based platforms (graphene, graphene oxide, and g-C₃N₄), and polymer matrices have been used as nanostructured solid supports for the successful fabrication of porphyrin-conjugated hybrid materials. The conjugation of porphyrin molecules to solid supports improves the photocatalytic degradation activity in terms of visible-light conversion ability, recyclability, active porous sites, substrate mobility, separation of photogenerated charge species, recovery for reuse, and chemical stability, along with preventing the generation of secondary pollution. This review discusses the ongoing development of porphyrin-conjugated hybrid nanomaterials for the heterogeneous photocatalytic degradation of organic dyes, pharmaceutical pollutants, heavy metals, pesticides, and human care in water. Several important results and advancements in the field allow for a more efficient wastewater remediation process. Full article

Coal combustion residues are often useful components for the cement industry. This study represents a material characterization and screening analysis by focusing on the mineralogical, physicochemical, and petrographic compositions of fly and bottom ash samples from four Greek power plants in order to evaluate their suitability and potential in industrial applications, especially as fillers in cement manufacturing. Proximate analysis revealed LOI values exceeding ASTM C618-22 limits. The sum of SiO₂, CaO, and Al₂O₃ classifies the studied samples as Class C except one. Iron and magnesium oxides are among the major components, while S, Ni, and Sr are also contained in significant amounts. Calcite, quartz, and plagioclases dominate, corresponding to their geochemical profile, while secondary mineral phases (i.e., neo-formed minerals during coal combustion) such as natrolite and gehlenite, were also identified. Relatively high amounts of carbonized organic matter and unburnt organic particles point to the incomplete combustion process, revealing the risk of slagging into the combustion chamber; this is confirmed through the high slagging and fouling indices. The amount of the magnetic fraction is low; magnetic spherules with complex surface structures and a wide range of spherule sizes were observed. While the pozzolanic character of the samples is strong, high values of LOI, S content, and carbonized organic material make them suitable for the cement industry after further treatment only. Full article

In silicon–carbon (Si-C) anode materials fabricated via chemical vapor deposition (CVD), the pore size distribution of porous carbon is a critical parameter that strongly affects the overall electrochemical performance. In this study, biomass-derived hard carbon was employed as the precursor, and porous carbon materials with distinct pore size characteristics were prepared via fluidized bed porosimetry after carbonization at different temperatures. Based on these porous carbon substrates, three types of Si-C anodes corresponding to low-, medium-, and high-temperature treatments were synthesized through a combination of SiH₄ deposition and carbon coating processes. Electrochemical evaluation demonstrated that all three Si-C anodes exhibited favorable electrochemical performance and suppressed volume expansion. Among them, the Si-C anode prepared at a medium temperature of 1100 °C, denoted as NT-P-SC, delivered the most balanced performance, achieving an initial coulombic efficiency of 94.47% together with excellent rate capability. Furthermore, when Si-C anodes derived from different porous carbon matrices were blended with graphite to achieve a composite capacity of 500 mAh/g and evaluated in full-cell configurations, the NT-P-SC silicon-based composite exhibited superior cycling stability. The composite delivered an initial discharge capacity of 3.53 mAh and maintained a capacity of 2.74 mAh after 1628 cycles, corresponding to a capacity retention of 77.62%. The improved electrochemical performance of the Si-C anode is primarily attributed to the optimized pore structure of the porous carbon matrix synergistically combined with the carbon coating process. Full article

Background/Objectives: Parasporin PS2Aa1, recently designated as Mpp46Aa1, is recognized for its selective anticancer activity against various human cell lines. In this study, specific regions of the native protein were fragmented, and targeted amino acid substitutions were introduced to improve cytotoxic selectivity and potency. Methods: The modified fragments were evaluated individually and in combination with curcumin, a polyphenol with well-documented anticancer properties, and Sacha inchi-derived matrices, known for their antioxidant and antiproliferative activities. Results: Experimental results demonstrated that the substituted variant designated T104L-G108W exhibited superior anticancer activity compared to the native peptide P102-K11. Synergism assays revealed that curcumin-bioconjugated peptides were more effective against the tested cell lines, whereas combinations with Sacha inchi reduced cytotoxicity, suggesting possible interference in the mechanisms of action. Functional assays, including caspase 3/7 and 9 activation, Annexin V-Cy3 staining, and cell viability analysis with 6-CFDA, confirmed increased sensitivity in SiHa and HeLa cell lines, particularly for peptide T104L-G108W. Conclusions: Collectively, these findings support the effectiveness of a substitution-based strategy in improving parasporin fragments and underscore the therapeutic potential of peptide T104L-G108W as a novel anticancer candidate. Furthermore, this study provides preliminary evidence that natural biomolecules can be optimized through targeted modifications and rational combinations, establishing a framework for the development of sustainable and selective therapeutic approaches in cancer treatment. Full article

Background/Objectives: Angelman syndrome is a neurodevelopmental disorder resulting from a deficiency of the maternally inherited UBE3A gene. In mature neurons, UBE3A expression is restricted to the maternal allele due to tissue-specific genomic imprinting, while the paternal allele is silenced in cis by the UBE3A antisense transcript (UBE3A-ATS). To date, numerous strategies have been employed to activate paternal UBE3A expression. In this study, we utilized RNA interference (RNAi) to investigate the downregulation of UBE3A-ATS in mouse primary neurons and human induced pluripotent stem cell (iPSC)-derived neurons. Methods: To induce paternal UBE3A expression, we employed small interfering RNA (siRNA) oligonucleotides (20 mouse candidates and 47 human candidates) and lentiviral short hairpin RNA (LV-shRNA) targeting SNORD115 to suppress UBE3A-ATS expression in both mouse primary neurons and iPSCs. Subsequently, we assessed the expression levels of Angelman syndrome-related neighboring and target genes at the transcript and, where applicable, protein levels. Results: Following treatment with siSnord115 or LV-shSnord115, we observed a reduction in Ube3a-ATS and a corresponding activation of paternal Ube3a RNA and protein expression in both Ube3a^P-YFP/m+ and Ube3a^p+/m− mouse primary neurons. A similar effect was observed upon treatment with LV-shSNORD115s in human iPSC-derived neurons. Conclusions: shRNA-mediated inhibition of Ube3a-ATS by targeting Snord115 effectively restores Ube3a/UBE3A expression in both mouse neurons and human iPSCs. While promising, the mild reduction in Snord116 raises concerns about potential off-target effects. AAV-based delivery of shRNA shows potential, but its translational applicability remains to be evaluated in vivo. Full article

This study presents a sustainable valorization strategy for wastewater treatment plant (WWTP) residual sands through their hydrothermal conversion into a dual-phase FAU/LTA zeolite and evaluates its adsorption performance toward methylene blue (MB) as a model cationic contaminant. The synthesized material (ZEO-RS) exhibited a low Si/Al ratio (~1.7), well-developed FAU supercages with minor LTA domains, and high structural integrity, as confirmed by XRD, FTIR, XRF, SEM and PZC analyses. ZEO-RS demonstrated rapid adsorption kinetics, reaching approximately 92% of equilibrium uptake within 30 min and following a pseudo-second-order kinetic model (k₂= 2.73 g·mg⁻¹·h⁻¹). Equilibrium data were best described by the Langmuir isotherm, yielding a maximum adsorption capacity of 34.2 mg·g⁻¹ at 20 °C, with favorable separation factors (0 < r_L < 1), while Freundlich fitting indicated moderate surface heterogeneity. Thermodynamic analysis revealed that MB adsorption is spontaneous (ΔG° = −11.98 to −12.56 kJ·mol⁻¹), mildly endothermic (ΔH° = +5.26 kJ·mol⁻¹), and entropy-driven (ΔS° = +0.059 kJ·mol⁻¹·K⁻¹). FTIR evidence, combined with pH-dependent behavior, indicates that adsorption proceeds via synergistic electrostatic attraction, pore confinement within FAU domains, and partial ion-exchange interactions. Desorption efficiencies conducted under mild acidic, neutral, and alkaline conditions resulted in low MB release (1–8%), indicating strong dye retention and high framework stability. Overall, the results demonstrate that WWTP residual sands are an effective and scalable low-cost precursor for producing zeolitic adsorbents, supporting their potential application in sustainable water purification and circular-economy-based wastewater treatment strategies. Full article

In recent years, remarkable progress in nanomedicine has been achieved, leading to the development of several nanocarriers which aim to enhance the therapeutic efficacy in cancer treatment. Owing to their high versatility and highly tunable physicochemical properties, alumina (Al₂O₃) and silica (SiO₂) substrates represent promising and innovative nanoplatforms that are widely used in biomedical applications, such as drug-delivery, diagnosis, and biosensing in cancer. In particular, such platforms possess multiple advantageous properties, including mechanical stability, high loading capacity, tunable porosity, excellent biocompatibility, and in vitro and in vivo low toxicity. In this review article, we discuss their emerging role as biosensing platforms and drug delivery systems in oncology. As such, we describe how these substrates enable the incorporation of antibodies against various cancer biomarkers [e.g., cancer antigen 15-3 (CA15-3), serum amyloid A1 (SAA1), epithelial cell adhesion molecule (EpCAM), or human epidermal growth factor receptor 2 (HER2)] for the detection of multiple malignancies. Furthermore, we highlight the development of highly promising alumina- and silica-based platforms for drug delivery (e.g., chemotherapeutics, photosensitizers, or gene delivery agents) in cancer. Ultimately, by providing a comprehensive overview alongside a critical analysis, we demonstrate that such nanostructures represent promising platforms for potential clinical translation in cancer medicine, helping to mitigate the limitations of conventional cancer therapies. Full article

Potyvirus genomes are expressed as a single large open reading frame, which is translated into a polyprotein that is post-translationally cleaved by three virus-encoded proteases into 10 functional proteins. Several of these potyviral proteins, including nuclear inclusion protein b (NIb), are multifunctional. Here, using the classic GFP silencing in Nicotiana benthamiana gfp-transgenic plants, we show that potato virus Y (PVY) NIb, in addition to its canonical role as the viral RNA-dependent RNA polymerase (RdRP), functions as a suppressor of RNA silencing. Mutational analyses reveal a previously unreported NIb nuclear localization signal (NLS) consisting of a triple-lysine motif. NIb suppression of RNA silencing activity was lost when the NLS was mutated, suggesting that nuclear localization is required for NIb suppression of RNA silencing activity. Analysis of sequenced GFP siRNAs revealed three reproducible hotspot regions at ≈175 nt, ≈320–330 nt, and a broader 3′-proximal region spanning ≈560–700 nt that contains multiple local maxima. These data show differences in the positional distribution of siRNAs between samples expressing NIb and those expressing NIb^Del3×2, the NIb null mutant that does not suppress RNA silencing. However, the positional distribution of GFP-derived small RNAs across the transgene differed modestly between NIb and NIb^Del3×2, while both treatments showed the same three reproducible hotspot regions. Furthermore, NIb was found to interact with four key RNA silencing pathway proteins—AGO4, HSP70, HSP90, and SGS3. Except for HSP90, each of these proteins showed degradation products that were absent in NIb mutants that did not suppress RNA silencing. These findings support a role for NIb in countering host defense during virus infection. Full article

The influence of electron beam treatment parameters (electron gun speed, electron beam current, scanning frequency, and sweep type) on the structure and properties of the surface layer of the composite material AlMg3-5SiC has been investigated. Composite specimens of AlMg₃ alloy reinforced with 5 wt.% silicon carbide particles were manufactured via the stir casting process. Experimentally, processing modes with heat input from 120 to 240 J/mm yield a modified layer thickness from 74 to 1705 µm. Heat input should not exceed 150 J/mm to ensure a smooth and defect-free surface layer. The macro- and microstructure were examined using optical microscopy. Brinell hardness was measured. Friction and wear tests were performed under dry sliding friction conditions using the “bushing on plate” scheme. This evaluated the tribological properties of the composite material in its original cast state and after modifying treatment. Due to the matrix alloy structure refinement by 5–10 times, the surface layer’s hardness increases by 11% after treatment. The modified specimens have superior tribological properties to the initial ones. Wear rate reduces by 17.5%, the average friction coefficient reduces by 32%, and the root mean squared error of the friction coefficient, which measures friction process stability, reduces by 50% at a specific load of 2.5 MPa. Therefore, the electron beam treatment process is a useful method for producing high-quality and uniform wear-resistant aluminum matrix composite surface layers. Full article

Glioblastoma multiforme (GBM) is characterized by aggressive growth, extensive vascularization, high metabolic malleability, and a striking capacity for therapy resistance. Current treatments involve surgical resection and concomitant radiation therapy and chemotherapy, prolonging survival times marginally due to the therapy resistance that is built up by the tumor cells. A growing body of research has identified exosomes as critical enablers of therapy resistance. These nanoscale vesicles enable GBM cells to disseminate oncogenic proteins, nucleic acids, and lipids that collectively promote angiogenesis, maintain autophagy under metabolic pressure, and suppress apoptosis. As interest grows in targeting tumor communication networks, exosome-based therapeutic strategies have emerged as promising avenues for improving therapeutic outcomes in GBM. This review integrates current insights into two complementary therapeutic strategies: inhibiting exosome biogenesis and secretion, and engineering exosomes as precision vehicles for the delivery of anti-tumor molecular cargo. Key molecular regulators of exosome formation—including the endosomal sorting complex required for transport (ESCRT) machinery, tumor susceptibility gene 101 (TSG101) protein, ceramide-driven pathways, and Rab GTPases—govern the sorting and release of factors that enhance GBM survival. Targeting these pathways through pharmacological or genetic means has shown promise in suppressing angiogenic signaling, disrupting autophagic flux via modulation of autophagy-related gene (ATG) proteins, and sensitizing tumor cells to apoptosis by destabilizing mitochondria and associated survival networks. In parallel, advances in exosome engineering—encompassing siRNA loading, miRNA enrichment, and small-molecule drug packaging—offer new routes for delivering therapeutic agents across the blood–brain barrier with high cellular specificity. Engineered exosomes carrying anti-angiogenic, autophagy-inhibiting, or pro-apoptotic molecules can reprogram the tumor microenvironment and activate both the intrinsic mitochondrial and extrinsic ligand-mediated apoptotic pathways. Collectively, current evidence underscores the potential of strategically modulating endogenous exosome biogenesis and harnessing exogenous engineered therapeutic exosomes to interrupt the angiogenic and autophagic circuits that underpin therapy resistance, ultimately leading to the induction of apoptotic cell death in GBM. Full article

Neuroblastoma is a highly aggressive pediatric malignancy originating from neural crest progenitor cells, predominantly in the adrenal medulla. Amplification of the MYCN oncogene occurs in 20–30% of all neuroblastoma cases and approximately 50% of high-risk tumors, strongly correlating with poor prognosis, relapse, and multidrug resistance. MYCN-driven oncogenesis promotes tumor progression by suppressing apoptotic signaling and enhancing survival pathways, including autophagy—a key mechanism underlying resistance to chemotherapy and immunotherapy. This review examines current therapeutic strategies and resistance mechanisms in MYCN-amplified neuroblastoma, while introducing emerging approaches utilizing exosomes as precision drug delivery systems. Exosomes, nanoscale extracellular vesicles secreted by the tumor cells, exhibit natural tropism and can be engineered to selectively target neuroblastoma-specific biomarkers such as glypican-2 (GPC2), which is highly expressed in MYCN-amplified tumors. Leveraging this property, neuroblastoma-derived exosomes can be purified, modified, and loaded with small interfering RNA (siRNA) to silence MYCN expression, combined with chloroquine—an FDA-approved autophagy inhibitor—to simultaneously inhibit autophagy and induce apoptotic signaling. This dual-targeted approach aims to overcome drug resistance, reduce off-target toxicity, and enhance therapeutic efficacy through exosome-mediated specificity. Furthermore, gut dysbiosis has emerged as a critical factor influencing tumor progression and diminishing treatment efficacy in MYCN-amplified neuroblastoma. We propose integrating microbiota-derived exosomes engineered to deliver anti-inflammatory microRNAs (miRNAs) to the gut mucosa, restoring eubiosis and potentiating systemic anti-tumor responses. Collectively, exosome-based strategies represent a paradigm shift in formulating combination therapies, offering a multifaceted approach to target MYCN amplification, inhibit autophagy, induce apoptosis, and modulate the tumor-microbiome axis. These innovations hold significant promise for improving clinical outcomes in high-risk MYCN-amplified neuroblastoma patients. Full article